Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5282068
Max Phase: Preclinical
Molecular Formula: C37H62O8Si
Molecular Weight: 662.98
Associated Items:
ID: ALA5282068
Max Phase: Preclinical
Molecular Formula: C37H62O8Si
Molecular Weight: 662.98
Associated Items:
Canonical SMILES: C[C@@H]1CC[C@H]2[C@@H](C)C(CC(CC3O[C@@H]4O[C@]5(C)CC[C@@H]6[C@@H](C)CC[C@H]([C@@H]3C)[C@]46OO5)C[Si](C)(C)C)O[C@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4
Standard InChI: InChI=1S/C37H62O8Si/c1-21-10-12-28-23(3)30(38-32-36(28)26(21)14-16-34(5,40-32)42-44-36)18-25(20-46(7,8)9)19-31-24(4)29-13-11-22(2)27-15-17-35(6)41-33(39-31)37(27,29)45-43-35/h21-33H,10-20H2,1-9H3/t21-,22+,23-,24+,25?,26+,27-,28+,29-,30?,31?,32+,33-,34-,35+,36-,37+
Standard InChI Key: XRJLIPDFYIWUAJ-GWEMCPIOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 662.98 | Molecular Weight (Monoisotopic): 662.4214 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Fröhlich T, Çapcı Karagöz A, Reiter C, Tsogoeva SB.. (2016) Artemisinin-Derived Dimers: Potent Antimalarial and Anticancer Agents., 59 (16): [PMID:27010926] [10.1021/acs.jmedchem.5b01380] |
Source(1):